companydata.dkcompanydata.dk

Fenucure Medical ApS: Financial statements 2024

CVR: 28486871

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Fenucure Medical ApS (CVR 28486871) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -873,428 and a net result of DKK -1,529,007 compared with DKK -2,107,951 the year before. Equity in the 2024 report amounted to DKK 795,238. The solvency ratio was 24.1%. The company had 2 employees in the financial year.

Gross Profit
DKK -873,428
Profit/Loss
DKK -1,529,007
Equity
DKK 795,238
Total Assets
DKK 3,300,277
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--873K-1.5M795K2
2023--912K-2.1M-1.7M2
2022--1.6M-3.5M-3.6M2
2021--1.7M-4.5M-2.5M2
2020--2.4M-3.2M-976K2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

V-BIOTEK HOLDING ApS registered as owner of Fenucure Medical ApSDec 20, 2024

As of December 20, 2024, V-BIOTEK HOLDING ApS is registered as an owner of Fenucure Medical ApS with an ownership share of 5%.

Redwood Foundation ApS registered as owner of Fenucure Medical ApSDec 20, 2024

As of December 20, 2024, Redwood Foundation ApS is registered as an owner of Fenucure Medical ApS with an ownership share of 5%.

Fenucure Medical ApS: The 2023 annual report is outMay 29, 2024

Fenucure Medical ApS has published its annual report for 2023. Gross profit came to DKK -911,893, and the net result was DKK -2,107,951.

About Fenucure Medical ApS

Fenucure Medical ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2005. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named V-BIOTEK ApS and VIND INVEST ApS. The management consists of Christian Hother Sørensen. The board consists of Nicolai Fink Gundersen (chair), Alex Gundersen, Mogens Viktor Madsen and Niels Christian Beck Vase. The company is owned by V-BIOTEK HOLDING ApS, Redwood Foundation ApS and Alex Gundersen Assens ApS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -1,214,608 and a net result of DKK -3,201,378 compared with DKK -1,529,007 the year before. Equity in the 2025 report amounted to DKK 593,861.

Source: annual report 2025, Danish Business Authority